What is notable from these early-stage studies is that identification of just T cell infiltration or the presence of an immunotherapy target, such as PD-L1, may be helpful co-correlates of the potential for response to immunotherapy treatment but might not be sufficient as the T cells in the tumor milieu may not potentiate anti-tumor activity in response to immunotherapy activation. Here, CD274 is linked to neoplasm.